Datametrex AI Signs LOI To Acquire Telemedicine Firm

Datametrex AI (TSXV: DM) this morning announced that it is looking to expand its presence in the healthcare space. The company has signed a letter of intent to acquire a private unnamed telemedicine company through an all-stock transaction for $12.0 million.

Datametrex AI's Logo

The acquisition target reportedly operates on a subscription basis, wherein it connects patients with health care providers and doctors in real time. The tech behind the operation is expected to be integrated with Datametrex’s AI-based tech on a post-closing basis.

The letter of intent is valid for a period of thirty days from the date of the signing of the LOI, after which the company will enter into a definitive agreement for the acquisition. The transaction is slated to take the form of a share acquisition, with Datametrex acquiring a 100% stake in the firm, after which point it will become a wholly owned subsidiary.

“The impact of the acquisition of this telemedicine AI business cannot be minimized. The demand for telemedicine continues to be a large area of growth particularly with the current pandemic. We believe that adding this telemedicine element to our existing AI business will drive significant value for our stakeholders.”

Marshall Gunter, CEO of Datametrex AI

Currently, a purchase price of $12.0 million has been slated for the target, with the purchase to be settled via the issuance of 60 million units of the company. Each unit is to contain one common share and one common share purchase warrant, valid at a price of $0.25 per warrant for a period of two years.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The transaction is currently dependent on the signing of a definitive agreement and approval of the firms board of directors. The proposed transaction is currently slated to close by April 15, 2021.

Datametrex AI last traded at $0.26 on the TSX Venture.


FULL DISCLOSURE: DataMetrex AI Limited is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover DataMetrex AI Limited on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Datametrex Secures Rights To New PCR Test Kit

Datametrex AI (TSXV: DM) continues to develop out its healthcare division focused on COVID-19 testing....

Monday, December 13, 2021, 07:35:57 AM

Datametrex AI Enters Definitive Agreement To Acquire Concierge Medical Telehealth Platform

Datametrex AI (TSXV: DM) this morning announced that it has signed a definitive agreement to...

Friday, January 22, 2021, 07:12:19 AM

Datametrex AI To Repurchase Up To 5% Of Shares

Datametrex AI (TSXV: DM) is looking to put its cash to work for shareholders. The...

Friday, June 3, 2022, 08:23:38 AM

Datametrex Secures Another $450,000 COVID-19 Test Kit Purchase Order

The checks just keep on coming in for Datametrex AI (TSXV: DM). The company announced...

Monday, June 8, 2020, 10:31:48 AM

Datametrex To Provide COVID-19 Testing For Air Canada Employees

Datametrex AI (TSXV: DM) this morning issued a brief press release, notifying the market that...

Monday, January 11, 2021, 07:21:54 AM